Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


Mar 29, 2023
New Analysis Shows Physician-owned Hospitals Cherry-pick Patients, Provide Less Uncompensated and Emergency Care.
Mar 29, 2023
AHA's feedback on a Drug Enforcement Administration proposed rule for the telemedicine prescribing of controlled substances when there has not been a prior in-person medical evaluation.
Mar 29, 2023
AHA provides feedback on the Drug Enforcement Administration’s (DEA’s) proposed rule for expansion of induction of buprenorphine via telemedicine encounter.
Mar 29, 2023
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Mar 28, 2023
The AHA writes to express support for the Rural America Health Corps Act (S.940).
Mar 23, 2023
AHA provides information for hearing on “Why Health Care is Unaffordable: The Fallout of Democrats’ Inflation on Patients and Small Businesses.”
Mar 21, 2023
AHA comments on the proposed Standards for Health Care Attachments Transactions and Electronic Signatures, and Modification to Referral Certification and Authorization Transaction Standard.
Mar 20, 2023
AHA responds to the RFI on the drivers of health care workforce shortages and solutions.
Mar 14, 2023
AHA comments on the Request for Information on the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Mar 13, 2023
AHA Comments on the Advancing Interoperability and Improving Prior Authorization Processes Proposed Rule
Mar 11, 2023
AHA comments on the Centers for Medicare & Medicaid Services’ initial guidance regarding certain Inflation Reduction Act requirements.
Mar 8, 2023
Hospitals and health systems are committed to empowering patients with all the information they need to live their healthiest lives. This includes ensuring they have access to accurate price information when seeking care. Our members are working to comply with both state and federal price transparency policies, which include the federal Hospital Price Transparency Rule and provisions in the No Surprises Act.
Mar 6, 2023
AHA, hospital organizations asks Congress to address the Medicaid disproportionate share hospital (DSH) cuts scheduled to begin in fiscal year (FY) 2024 to ensure patients continue to have access to quality care.
Mar 3, 2023
AHA appreciates the opportunity to comment on the Department of Health and Human Services’ proposed rule regarding statutory conscience protections.
Feb 22, 2023
AHA letter to Representative Troy Balderson expressing support of H.R. 1110, the Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act.
Feb 22, 2023
The AHA opposes the Federal Trade Commission’s (FTC) proposed Non-Compete Clause Rule in its current form.
Feb 16, 2023
AHA shares comments on two topics that were discussed during the January 2023 public meeting: Medicare Part B drug payments and telehealth services.
Feb 15, 2023
AHA provides additional recommendations on implementation of the independent dispute resolution (IDR) process included in the No Surprises Act.
Feb 13, 2023
AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) information collection request regarding the revision of the Medicare Enrollment Application for Institutional Providers (CMS-855A).